Grant: Discovery Grants Program - Individual
University of Western Ontario
$45,000.00
Chemical Synthesis and Applications of Oligonucleotide Analogues
EF 2017-18
Résumé
My research program is concerned with the development of structurally modified oligonucleotides (DNA and RNA) and non-natural oligonucleotide mimics such as peptide nucleic acid (PNA and PMO) that: (1) expand our understanding of the chemistry, function and biology of nucleic acids; (2) will serve as sequence probes and biomolecular tools for other areas of study; and (3) may act as artificial regulators of gene expression. Another area of research is dedicated to the design, synthesis, understanding and application of contrast agents for medical imaging by magnetic resonance (MR) and positron emission tomography (PET). Our work in the field of nucleic acid chemistry is driven by the continuing need for new biomolecular tools. Synthetic oligomers can be used as probes for diagnostics, for antisense, antigene, anti-miRNA or RNAi-based target validation studies, as aptamers and aptasensors, and in the area of functional genomics or as actual chemotherapeutics. Due to the strength in medical imaging at the Robarts Research Institute at Western University and at London Health Sciences network we have had the opportunity to build a program in the discovery of new imaging agents for serious diseases such as cancer and Alzheimers. This work is undertaken by a cohort of talented undergraduate, graduate and postdoctoral fellows who combine traditional solution phase small molecule synthesis with solid-phase syntheses, and key instrumental techniques. We collaborate with fellow researchers in Canada and abroad in nucleic acid chemistry and medical imaging. Thus, trainees graduate from my lab well-prepared to enter the professions in Chemistry and allied sciences as well as professional programs with an appreciation for the global nature of Science.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2017-05389
Name nom
Hudson, Robert
Department département
Chemistry - Chemistry
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
45000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
1
Nb partie
5
Application title
Chemical Synthesis and Applications of Oligonucleotide Analogues
Keyword
NSERC
Application summary
My research program is concerned with the development of structurally modified oligonucleotides (DNA and RNA) and non-natural oligonucleotide mimics such as peptide nucleic acid (PNA and PMO) that: (1) expand our understanding of the chemistry, function and biology of nucleic acids; (2) will serve as sequence probes and biomolecular tools for other areas of study; and (3) may act as artificial regulators of gene expression. Another area of research is dedicated to the design, synthesis, understanding and application of contrast agents for medical imaging by magnetic resonance (MR) and positron emission tomography (PET). Our work in the field of nucleic acid chemistry is driven by the continuing need for new biomolecular tools. Synthetic oligomers can be used as probes for diagnostics, for antisense, antigene, anti-miRNA or RNAi-based target validation studies, as aptamers and aptasensors, and in the area of functional genomics or as actual chemotherapeutics. Due to the strength in medical imaging at the Robarts Research Institute at Western University and at London Health Sciences network we have had the opportunity to build a program in the discovery of new imaging agents for serious diseases such as cancer and Alzheimers. This work is undertaken by a cohort of talented undergraduate, graduate and postdoctoral fellows who combine traditional solution phase small molecule synthesis with solid-phase syntheses, and key instrumental techniques. We collaborate with fellow researchers in Canada and abroad in nucleic acid chemistry and medical imaging. Thus, trainees graduate from my lab well-prepared to enter the professions in Chemistry and allied sciences as well as professional programs with an appreciation for the global nature of Science.